TapewireFind a company

person · Reporting owner

Wheeler Benjamin Richard

Disclosed activity across 1 company

Tapewire entity
23084
SEC CIK
0002082246

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
MYRIAD GENETICS INCMYGN · Entity 5953Chief Financial OfficerSeptember 21, 2026September 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

MYRIAD GENETICS INC

Report date September 21, 2026 · Filed September 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect287,193 Reported balance After 2026-09-21 transaction · row 1
1 source row

Row 1 · 2026-09-21 · Tax withholding · Disposed 2,555 · Balance 287,193

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 21, 2026 Filed Sep 22, 2026 20:12 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 2,555 $4.01 $10,245.55
Disclosure

SEC source: 0002082246-26-000010 · wk-form4_1790107917.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,193

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026.

Read SEC document
August 16, 2026 Filed Aug 17, 2026 20:26 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 8,761 $3.03 $26,545.83
Disclosure

SEC source: 0002082246-26-000008 · wk-form4_1786998358.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,748

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on August 14, 2026.

Read SEC document
March 22, 2026 Filed Mar 23, 2026 20:22 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 549 $4.58 $2,514.42
Disclosure

SEC source: 0002082246-26-000006 · wk-form4_1774297370.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 298,509

F1 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026.

Read SEC document
March 15, 2026 Filed Mar 16, 2026 21:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 2,192 $4.66 $10,214.72
Disclosure

SEC source: 0002082246-26-000004 · wk-form4_1773695129.xml · nonDerivative · entry 5

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,058

F3 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026.

Read SEC document
March 15, 2026 Filed Mar 16, 2026 21:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 877 $4.66 $4,086.82
Disclosure

SEC source: 0002082246-26-000004 · wk-form4_1773695129.xml · nonDerivative · entry 4

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,250

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
March 14, 2026 Filed Mar 16, 2026 21:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 1,097 $4.66 $5,112.02
Disclosure

SEC source: 0002082246-26-000004 · wk-form4_1773695129.xml · nonDerivative · entry 3

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,127

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 21:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 586 $4.66 $2,730.76
Disclosure

SEC source: 0002082246-26-000004 · wk-form4_1773695129.xml · nonDerivative · entry 2

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,224

F2 · shares: Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 21:05 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 206,186 $0.00 $0.00
Disclosure

SEC source: 0002082246-26-000004 · wk-form4_1773695129.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,810

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document
February 02, 2026 Filed Feb 3, 2026 22:30 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 4,994 $0.00 $0.00
Disclosure

SEC source: 0002082246-26-000002 · wk-form4_1770157811.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,624

F1 · shares: Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026.

Read SEC document
December 25, 2025 Filed Dec 29, 2025 21:30 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 21 $6.55 $137.55
Disclosure

SEC source: 0002082246-25-000008 · wk-form4_1767043825.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,630

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 24, 2025.

Read SEC document
September 21, 2025 Filed Sep 22, 2025 20:14 UTC MYRIAD GENETICS INC MYGN · Entity 5953 Tax withholdingCommon Stock 2,559 $7.77 $19,883.43
Disclosure

SEC source: 0002082246-25-000006 · wk-form4_1758572074.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,651

F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025.

Read SEC document
August 16, 2025 Filed Aug 19, 2025 21:24 UTC MYRIAD GENETICS INC MYGN · Entity 5953 GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0002082246-25-000004 · wk-form4_1755638655.xml · nonDerivative · entry 1

Wheeler Benjamin Richard · CIK 0002082246 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,210

F1 · shares: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.